ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib

by Chen Wang, Nicholas Jette, Daniel Moussienko, D. Gwyn Bebb, Susan P. Lees-Miller
Published 2017-04-01

CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients.

by Andrea S Fung, Karen Kopciuk, Michelle L Dean, Adrijana D'Silva, Shannon Otsuka, Alexander Klimowicz, Desiree Hao, Don Morris, D Gwyn Bebb
Published 2021-01-01

Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada

by Dylan E. O’Sullivan, Winson Y. Cheung, Iqra A. Syed, Daniel Moldaver, Mary Kate Shanahan, D. Gwyn Bebb, Christina Sit, Darren R. Brenner, Devon J. Boyne
Published 2021-08-01

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

by Daniel E. Meyers, Igor Stukalin, Isabelle A. Vallerand, Ryan T. Lewinson, Aleksi Suo, Michelle Dean, Scott North, Aliyah Pabani, Tina Cheng, Daniel Y.C. Heng, D. Gwyn Bebb, Don G. Morris
Published 2019-11-01

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors

by Amanda J.W. Gibson, BSc (Hons), Adrian Box, MD, PhD, Michelle L. Dean, BSc, Anifat A. Elegbede, MSc, Desiree Hao, MD, Randeep Sangha, MD, D. Gwyn Bebb, BMBCh, PhD
Published 2021-04-01

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults

by D. Gwyn Bebb, Shantanu Banerji, Normand Blais, Patrice Desmeules, Sharlene Gill, Andrea Grin, Harriet Feilotter, Aaron R. Hansen, Martin Hyrcza, Monika Krzyzanowska, Barbara Melosky, Jonathan Noujaim, Bibiana Purgina, Dean Ruether, Christine E. Simmons, Denis Soulieres, Emina Emilia Torlakovic, Ming-Sound Tsao
Published 2021-01-01